BIBLIOGRAPHIC RECORD

Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
David P. Walling; Stephen R. Marder; John Michael Kane; W. Wolfgang Fleischhacker; Richard S.E. Keefe; David A. Hosford; Chris Dvergsten; Anthony C. Segreti; Jessica S. Beaver; Steven M. Toler; John E Jett; Geoffrey C. Dunbar
Source of metadata
OpenAlex
Year recorded
2015

Public identifiers and source

Open the source record

Reference

David P. Walling; Stephen R. Marder; John Michael Kane; W. Wolfgang Fleischhacker; Richard S.E. Keefe; David A. Hosford; Chris Dvergsten; Anthony C. Segreti; Jessica S. Beaver; Steven M. Toler; John E Jett; Geoffrey C. Dunbar. (2015). Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia. https://openalex.org/W2263665616

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-0e1c2bbc257df17db27a0bb02fe8104f/